Lipid Metabolism Practice Questions

Q: Which of the following is the rate-limiting enzyme of bile acid synthesis?

Microsomal 7 α-hydroxylase. **Explanation:** The synthesis of bile acids from cholesterol is the primary pathway for cholesterol excretion in the body. This process occurs in the liver and is regulated by a critical rate-limiting step. **Why Option C is correct:** The enzyme **7 α-hydroxylase** catalyzes the first and most important regulatory step in bile acid synthesis, converting cholesterol into 7 α-hydroxycholesterol. This enzyme is a **microsomal** enzyme (located in the endoplasmic reticulum) and belongs to the cytochrome P450 superfamily (CYP7A1). It requires NADPH, molecular oxygen, and Vitamin C as cofactors. **Analysis of Incorrect Options:** * **Option A:** 17 α-hydroxylase is involved in the synthesis of steroid hormones (adrenal and gonadal steroids), not bile acids. * **Option B:** While the enzyme name is correct, its localization is wrong. 7 α-hydroxylase is membrane-bound in the microsomes, not free in the cytoplasm. * **Option C vs D:** The distinction between microsomal and mitochondrial is a common "trap" in NEET-PG. While some later steps in the "alternative pathway" of bile acid synthesis occur in mitochondria (via 27-hydroxylase), the **primary rate-limiting step** (CYP7A1) is strictly **microsomal**. **High-Yield Clinical Pearls for NEET-PG:** * **Feedback Inhibition:** Bile acids (the end product) inhibit 7 α-hydroxylase via the Farnesoid X Receptor (FXR). * **Vitamin C Deficiency:** Scurvy can lead to cholesterol accumulation and gallstone formation because Vitamin C is a necessary cofactor for 7 α-hydroxylase. * **Thyroid Connection:** Thyroid hormones (T3) upregulate this enzyme; thus, hypothyroidism often presents with hypercholesterolemia due to decreased bile acid conversion. * **Bile Acid Sequestrants:** Drugs like Cholestyramine increase the activity of this enzyme by removing the feedback inhibition of bile acids.

Q: Apolipoproteins E and C are synthesized by which organ?

Liver. ### Explanation **1. Why the Correct Answer is Right:** The **liver** is the primary metabolic hub for lipid synthesis and transport. It is the major site for the synthesis of most apolipoproteins, including **Apo C (C-I, C-II, C-III)** and **Apo E**. * **Apo C-II** is a vital cofactor that activates Lipoprotein Lipase (LPL) for triglyceride hydrolysis. * **Apo E** serves as the essential ligand for the hepatic uptake of chylomicron remnants and IDL via the LDL receptor and LRP (LDL Receptor-related Protein). While the intestine synthesizes specific apolipoproteins (like Apo B-48 and Apo A-I), the bulk of the circulating "exchangeable" apolipoproteins (C and E) are produced and secreted by hepatocytes into the plasma, where they are primarily associated with VLDL and HDL. **2. Why the Incorrect Options are Wrong:** * **Kidney:** The kidneys are involved in the filtration and reabsorption of small molecules but do not possess the biosynthetic machinery for lipoprotein assembly or apolipoprotein synthesis. * **Intestine:** The enterocytes are responsible for synthesizing **Apo B-48** (unique to chylomicrons) and some **Apo A-I**. While they contribute small amounts of Apo A-IV, they are not the source of Apo C or Apo E. * **RBCs:** Red blood cells lack a nucleus and organelles (ribosomes/ER); therefore, they cannot synthesize proteins. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Apo B-100 vs. B-48:** Remember that Apo B-100 is made in the **Liver**, while Apo B-48 is made in the **Intestine** (due to RNA editing by the enzyme *cytidine deaminase*). * **Apo C-II Deficiency:** Leads to Type I Hyperlipoproteinemia (marked elevation of Chylomicrons). * **Apo E Deficiency:** Leads to Type III Hyperlipoproteinemia (Dysbetalipoproteinemia), characterized by the accumulation of IDL and Chylomicron remnants. * **Alzheimer’s Link:** The **Apo E4** isoform is a significant genetic risk factor for late-onset Alzheimer’s disease.

Q: An individual with hypertriglyceridemia has a triglyceride level of 350 mg/dL. The patient switches to a low-fat, low-protein, high-carbohydrate diet while maintaining the same caloric intake. Three months later, his triglyceride level has increased to 375 mg/dL. Which component of his new diet is responsible for this increase in lipid content?

Carbohydrates. ### Explanation **1. Why Carbohydrates are Correct:** The phenomenon observed in this patient is known as **Carbohydrate-Induced Hypertriglyceridemia**. When a diet is high in refined carbohydrates (especially fructose and glucose), the liver undergoes increased **de novo lipogenesis**. * Excess glucose is converted into Acetyl-CoA, which serves as the precursor for fatty acid synthesis. * These fatty acids are esterified into triglycerides and packaged into **Very Low-Density Lipoproteins (VLDL)** for secretion into the blood. * High carbohydrate intake also stimulates insulin release, which promotes fatty acid synthesis and inhibits fatty acid oxidation, further elevating plasma triglyceride levels. **2. Why Other Options are Incorrect:** * **Phospholipids (A):** These are structural components of cell membranes and do not significantly contribute to the bulk of plasma triglyceride levels. * **Triglycerides (B):** The patient switched to a *low-fat* diet. If dietary triglycerides were the cause, the levels should have decreased, as dietary fats are transported via chylomicrons. * **Amino acids (C):** The patient switched to a *low-protein* diet. While carbon skeletons of amino acids can enter lipogenesis, the reduction in protein intake makes them an unlikely cause for the rise in lipids in this specific scenario. **3. Clinical Pearls for NEET-PG:** * **VLDL vs. Chylomicrons:** Endogenous triglycerides (from carbs) are carried by **VLDL** (Apo B-100), while exogenous triglycerides (from diet) are carried by **Chylomicrons** (Apo B-48). * **Rate-limiting enzyme:** Acetyl-CoA Carboxylase (ACC) is the key enzyme in fatty acid synthesis, stimulated by insulin. * **High-Yield Fact:** Fructose is more lipogenic than glucose because it bypasses the major regulatory step of glycolysis (Phosphofructokinase-1), leading to rapid VLDL production.

Q: All of the following are diseases occurring due to disturbance in lipid metabolism except?

Hurler syndrome. **Explanation:** The core of this question lies in distinguishing between **Sphingolipidoses** (Lipid Storage Disorders) and **Mucopolysaccharidoses** (GAG Storage Disorders). **Why Hurler Syndrome is the correct answer:** Hurler Syndrome (MPS Type I) is a **Mucopolysaccharidosis**. It is caused by a deficiency of the enzyme **$\alpha$-L-iduronidase**, leading to the systemic accumulation of **Glycosaminoglycans (GAGs)**, specifically Dermatan sulfate and Heparan sulfate. It is characterized by coarse facial features, corneal clouding, and hepatosplenomegaly, but it is fundamentally a disorder of carbohydrate (GAG) metabolism, not lipid metabolism. **Analysis of Incorrect Options:** * **Gaucher’s Disease:** The most common lysosomal storage disorder. It is a lipid metabolism disturbance caused by **Glucocerebrosidase** deficiency, leading to the accumulation of Glucocerebroside. * **Niemann-Pick Disease:** A lipid storage disorder caused by **Sphingomyelinase** deficiency, resulting in the accumulation of Sphingomyelin. It classically presents with a "cherry-red spot" on the macula and hepatosplenomegaly. * **Letterer-Siwe Disease:** This is the most severe, systemic form of **Langerhans Cell Histiocytosis (LCH)**. It involves the proliferation of Langerhans cells which are laden with lipids (cholesterol), historically classifying it under "Hand-Schüller-Christian complex" or lipid-related histiocytosis. **NEET-PG High-Yield Pearls:** * **Corneal Clouding:** Present in Hurler Syndrome (MPS I) but **absent** in Hunter Syndrome (MPS II). * **Inheritance:** Most lysosomal storage diseases are Autosomal Recessive, EXCEPT **Hunter Syndrome** and **Fabry Disease**, which are **X-linked Recessive**. * **Gaucher Cells:** Characterized by a "wrinkled tissue paper" appearance of the cytoplasm.

Q: Which of the following statements about Thromboxane A2 (TXA2) is false?

It possesses platelet anti-aggregatory reactivity.. ### Explanation **Why Option C is the Correct (False) Statement:** Thromboxane A2 (TXA2) is a potent **pro-aggregatory** agent. It is released by activated platelets to promote platelet aggregation and induce vasoconstriction. Its primary physiological role is to facilitate the formation of a platelet plug during hemostasis. The statement that it possesses "anti-aggregatory" reactivity is incorrect; that property belongs to **Prostacyclin (PGI2)**, which is produced by vascular endothelial cells to inhibit aggregation and cause vasodilation. **Analysis of Incorrect Options:** * **Option A:** TXA2 is synthesized primarily in **platelets** via the enzyme Thromboxane synthase. * **Option B:** The precursor for all prostanoids is Arachidonic acid, which is converted by Cyclooxygenase (COX) into the cyclic endoperoxides **PGG2 and PGH2**. TXA2 is then derived specifically from PGH2. * **Option C:** **Aspirin** irreversibly inhibits the **COX-1 enzyme** by acetylation. Since platelets are anuclear and cannot synthesize new enzymes, aspirin effectively shuts down TXA2 production for the lifespan of the platelet (7–10 days). **NEET-PG Clinical Pearls:** * **The "Prostacyclin-Thromboxane Balance":** Normal vascular health depends on the balance between PGI2 (anti-aggregatory/vasodilator) and TXA2 (pro-aggregatory/vasoconstrictor). * **Low-dose Aspirin:** Used for cardioprotection because it inhibits platelet TXA2 more significantly than endothelial PGI2 (as endothelial cells can regenerate COX enzymes). * **Half-life:** TXA2 is highly unstable with a very short half-life (approx. 30 seconds), rapidly hydrating to the biologically inactive **TXB2**.

Q: What enzyme hydrolyzes storage triacylglycerols?

Hormone-sensitive lipase. **Explanation:** The mobilization of stored fat from adipose tissue is a tightly regulated process known as lipolysis. **1. Why Hormone-sensitive lipase (HSL) is correct:** HSL is the key regulatory enzyme responsible for the hydrolysis of **storage triacylglycerols** (TAGs) within adipocytes into free fatty acids and glycerol. It is called "hormone-sensitive" because its activity is regulated by covalent modification: it is activated by **Glucagon and Epinephrine** (via cAMP-mediated phosphorylation) during fasting or stress, and inhibited by **Insulin** (via dephosphorylation) in the well-fed state. **2. Why other options are incorrect:** * **Pancreatic lipase:** Responsible for the hydrolysis of **dietary TAGs** in the small intestine. It requires colipase for its function. * **Lipoprotein lipase (LPL):** Located on the capillary endothelium. It hydrolyzes TAGs found in **circulating lipoproteins** (Chylomicrons and VLDL) to provide fatty acids to extrahepatic tissues. * **Lysosomal lipase:** Involved in the degradation of lipids internalized via endocytosis; it is not the primary enzyme for mobilizing bulk adipose stores. **3. High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting step:** While HSL is the major regulated enzyme, **Adipose Triglyceride Lipase (ATGL)** initiates the process by converting TAG to Diacylglycerol (DAG). * **Inhibitor:** Niacin (Vitamin B3) inhibits HSL, reducing the mobilization of fatty acids, which is why it is used to treat hyperlipidemia. * **Product Fate:** Glycerol released by HSL cannot be reused by adipocytes (due to lack of *glycerol kinase*); it travels to the liver for gluconeogenesis.

Q: Abetalipoproteinemia results in the absence of which of the following?

All of the above. **Explanation:** **Abetalipoproteinemia** (Bassen-Kornzweig syndrome) is an autosomal recessive disorder caused by a mutation in the **Microsomal Triglyceride Transfer Protein (MTP)** gene. MTP is essential for loading lipids onto **Apolipoprotein B (Apo B)**. 1. **Why "All of the above" is correct:** Apo B is the structural scaffolding for several lipoproteins. There are two primary isoforms: * **Apo B-48:** Required for the assembly and secretion of **Chylomicrons** in the enterocytes (intestine). * **Apo B-100:** Required for the assembly and secretion of **VLDL** in the hepatocytes (liver). Since **LDL** is the metabolic end-product of VLDL (VLDL → IDL → LDL), the absence of VLDL inevitably leads to the absence of LDL. In Abetalipoproteinemia, the failure of MTP means neither Apo B-48 nor Apo B-100 can be lipidated; consequently, Chylomicrons, VLDL, and LDL are all virtually absent from the plasma. 2. **Analysis of Options:** * **Options A, B, and C** are individually correct but incomplete. Because the defect affects the common assembly mechanism for all Apo B-containing lipoproteins, the deficiency is global across these classes. 3. **High-Yield Clinical Pearls for NEET-PG:** * **Lipid Profile:** Extremely low cholesterol and triglycerides from birth. * **Biopsy Findings:** Intestinal biopsy shows **lipid-laden enterocytes** (steatosis) because dietary fats are absorbed but cannot be exported as chylomicrons. * **Clinical Presentation:** Malabsorption (steatorrhea), failure to thrive, and deficiencies of fat-soluble vitamins (A, D, E, K). * **Hematology:** Presence of **Acanthocytes** (spur cells) on peripheral smear due to altered RBC membrane lipids. * **Neurological:** Vitamin E deficiency leads to spinocerebellar degeneration and retinitis pigmentosa.

Q: A patient is prescribed a medication to deter alcohol consumption due to repeated DUI citations. This medication induces nausea and vomiting upon alcohol ingestion. The drug-induced illness is caused by the buildup of which one of the following metabolites?

Acetaldehyde. **Explanation:** The medication described is **Disulfiram**, which is used in the treatment of chronic alcoholism. It acts as a deterrent by causing an extremely unpleasant physiological reaction when alcohol is consumed. **Why Acetaldehyde is correct:** Alcohol metabolism primarily occurs in the liver via two steps: 1. **Ethanol** is converted to **Acetaldehyde** by the enzyme *Alcohol Dehydrogenase*. 2. **Acetaldehyde** is then converted to **Acetate** by the enzyme **Aldehyde Dehydrogenase (ALDH)**. Disulfiram irreversibly inhibits **Aldehyde Dehydrogenase**. When a patient on Disulfiram drinks alcohol, acetaldehyde cannot be converted to acetate, leading to a 5–10 fold increase in blood acetaldehyde levels. This "Acetaldehyde Syndrome" manifests as flushing, tachycardia, hypotension, nausea, and severe vomiting. **Why incorrect options are wrong:** * **A. Ethanol:** This is the parent compound. While its levels remain high, it is the toxic metabolite (acetaldehyde), not ethanol itself, that causes the acute illness. * **C & D. Acetate and Acetyl-CoA:** These are the subsequent products of normal alcohol metabolism. Because ALDH is inhibited, the pathway is blocked *before* these metabolites can be formed in significant quantities. **NEET-PG High-Yield Pearls:** * **Disulfiram-like reaction:** Several other drugs inhibit ALDH and cause similar reactions. Mnemonic: **"PM GCT"** (**P**rocarbazine, **M**etronidazole, **G**riseofulvin, **C**ephalosporins [Cefoperazone/Cefotetan], **T**olbutamide). * **Fomepizole:** Inhibits *Alcohol Dehydrogenase*; used as an antidote for Methanol or Ethylene Glycol poisoning. * **Rate-limiting step:** Alcohol metabolism follows **zero-order kinetics** (a constant amount of drug is eliminated per unit time).

Q: Heparin helps in the release of which enzyme?

Lipoprotein lipase. **Explanation:** The correct answer is **Lipoprotein lipase (LPL)**. Lipoprotein lipase is an enzyme primarily found on the luminal surface of capillary endothelial cells, anchored by **heparan sulfate proteoglycans**. Its primary role is to hydrolyze triglycerides in chylomicrons and VLDL into free fatty acids and glycerol. When heparin is administered intravenously, it displaces LPL from its binding sites on the endothelium into the bloodstream. This leads to a rapid increase in plasma LPL activity, a phenomenon known as the **"lipemia clearing effect."** **Analysis of Incorrect Options:** * **Hyaluronidase (A):** This enzyme degrades hyaluronic acid. While heparin is a glycosaminoglycan like hyaluronic acid, it does not trigger the release of this enzyme. * **Amylase (C):** This is a digestive enzyme produced by the pancreas and salivary glands for carbohydrate breakdown; its secretion is regulated by hormonal and neural signals, not heparin. * **Invertase (D):** Also known as sucrase, this enzyme breaks down sucrose into glucose and fructose in the intestinal brush border. It is unrelated to heparin or lipid metabolism. **High-Yield Clinical Pearls for NEET-PG:** * **Cofactor:** LPL requires **Apo C-II** as an essential cofactor for its activation. * **Inhibitor:** **Apo C-III** and **Apo A-II** act as inhibitors of LPL. * **Diagnostic Use:** The "Post-heparin lipolytic activity" (PHLA) test is used to diagnose **Type I Hyperlipoproteinemia** (Familial LPL deficiency), where LPL activity remains low even after heparin injection. * **Insulin Connection:** Insulin stimulates the synthesis and secretion of LPL in adipose tissue, promoting fat storage in the fed state.

Q: Which steroid is formed from cholesterol without hydroxylation?

Progesterone. **Explanation:** The conversion of cholesterol to steroid hormones begins in the mitochondria. The first and rate-limiting step is the conversion of **Cholesterol to Pregnenolone** by the enzyme **Cholesterol side-chain cleavage enzyme (P450scc/Desmolase)**. This step involves hydroxylation. However, the subsequent conversion of **Pregnenolone to Progesterone** is catalyzed by **3β-hydroxysteroid dehydrogenase (3β-HSD)**. This reaction involves the **oxidation** of the hydroxyl group at carbon 3 to a ketone group and the isomerization of the double bond. Crucially, this specific step **does not require hydroxylation**. Therefore, Progesterone is the first steroid in the biosynthetic pathway that can be formed from the immediate precursor (pregnenolone) without an additional hydroxylation step. **Analysis of Incorrect Options:** * **B & C (Glucocorticoids & Mineralocorticoids):** The synthesis of cortisol and aldosterone requires multiple hydroxylation steps at positions C11, C17, and C21 (via 11β-hydroxylase, 17α-hydroxylase, and 21-hydroxylase). * **D (Estradiol):** Estrogen synthesis involves complex modifications including hydroxylation and the aromatization of the A-ring. **NEET-PG High-Yield Pearls:** * **Rate-limiting step:** Cholesterol → Pregnenolone (catalyzed by Desmolase/P450scc). * **StAR Protein:** Steroidogenic Acute Regulatory protein is essential for transporting cholesterol into the mitochondria; its deficiency causes Congenital Lipoid Adrenal Hyperplasia. * **Location:** Steroidogenesis occurs in the **Adrenal Cortex, Ovaries, Testes, and Placenta**. * **Precursor:** All steroid hormones are derived from a **27-carbon cholesterol** skeleton.

Question 1

Which of the following is the rate-limiting enzyme of bile acid synthesis?

Accepted Answer

Microsomal 7 α-hydroxylase

Answer

Mitochondrial 17 α-hydroxylase

Answer

Cytoplasmic 7 α-hydroxylase

Answer

Mitochondrial 7 α-hydroxylase

Question 2

Apolipoproteins E and C are synthesized by which organ?

Accepted Answer

Liver

Answer

Kidney

Answer

Intestine

Answer

RBCs

Question 3

An individual with hypertriglyceridemia has a triglyceride level of 350 mg/dL. The patient switches to a low-fat, low-protein, high-carbohydrate diet while maintaining the same caloric intake. Three months later, his triglyceride level has increased to 375 mg/dL. Which component of his new diet is responsible for this increase in lipid content?

Accepted Answer

Carbohydrates

Answer

Phospholipids

Answer

Triglycerides

Answer

Amino acids

Question 4

All of the following are diseases occurring due to disturbance in lipid metabolism except?

Accepted Answer

Hurler syndrome

Answer

Gaucher’s Disease

Answer

Niemann-Pick Disease

Answer

Letterer-Siwe Disease

Question 5

Which of the following statements about Thromboxane A2 (TXA2) is false?

Accepted Answer

It possesses platelet anti-aggregatory reactivity.

Answer

It is formed in platelets.

Answer

It is formed from PGG2/H2.

Answer

Aspirin can inhibit its production.

Question 6

What enzyme hydrolyzes storage triacylglycerols?

Accepted Answer

Hormone-sensitive lipase

Answer

Pancreatic lipase

Answer

Lipoprotein lipase

Answer

Lysosomal lipase

Question 7

Abetalipoproteinemia results in the absence of which of the following?

Accepted Answer

All of the above

Answer

Chylomicrons

Answer

Low-density lipoprotein (LDL)

Answer

Very low-density lipoprotein (VLDL)

Question 8

A patient is prescribed a medication to deter alcohol consumption due to repeated DUI citations. This medication induces nausea and vomiting upon alcohol ingestion. The drug-induced illness is caused by the buildup of which one of the following metabolites?

Accepted Answer

Acetaldehyde

Answer

Ethanol

Answer

Acetate

Answer

Acetyl-CoA

Question 9

Heparin helps in the release of which enzyme?

Accepted Answer

Lipoprotein lipase

Answer

Hyaluronidase

Answer

Amylase

Answer

Invertase

Question 10

Which steroid is formed from cholesterol without hydroxylation?

Accepted Answer

Progesterone

Answer

Glucocorticoid

Answer

Mineralocorticoid

Answer

Estradiol

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?